High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial von Massard, Christophe, Michiels, Stefan, Ferté, Charles, Le Deley, Marie-Cécile, Lacroix, Ludovic, Hollebecque, Antoine, Verlingue, Loic, Ileana, Ecaterina, Rosellini, Silvia, Ammari, Samy, Ngo-Camus, Maud, Bahleda, Rastislav, Gazzah, Anas, Varga, Andrea, Postel-Vinay, Sophie, Loriot, Yohann, Even, Caroline, Breuskin, Ingrid, Auger, Nathalie, Job, Bastien, De Baere, Thierry, Deschamps, Frederic, Vielh, Philippe, Scoazec, Jean-Yves, Lazar, Vladimir, Richon, Catherine, Ribrag, Vincent, Deutsch, Eric, Angevin, Eric, Vassal, Gilles, Eggermont, Alexander, André, Fabrice, Soria, Jean-Charles

Volltext

Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651 von Haddad, Robert I, Harrington, Kevin, Tahara, Makoto, Ferris, Robert L, Gillison, Maura, Fayette, Jerome, Daste, Amaury, Koralewski, Piotr, Zurawski, Bogdan, Taberna, Miren, Saba, Nabil F, Mak, Milena, Kawecki, Andrzej, Girotto, Gustavo, Alvarez Avitia, Miguel Angel, Even, Caroline, Toledo, Joaquin Gabriel Reinoso, Guminski, Alexander, Müller-Richter, Urs, Kiyota, Naomi, Roberts, Mustimbo, Khan, Tariq Aziz, Miller-Moslin, Karen, Wei, Li, Argiris, Athanassios

Volltext

A conflict-based path-generation heuristic for evacuation planning von Pillac, Victor, Van Hentenryck, Pascal, Even, Caroline

Volltext

Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity von Marret, Grégoire, Temam, Stéphane, Kamal, Maud, Even, Caroline, Delord, Jean-Pierre, Hoffmann, Caroline, Dolivet, Gilles, Malard, Olivier, Fayette, Jérôme, Capitain, Olivier, Vergez, Sébastien, Geoffrois, Lionel, Rolland, Frédéric, Zrounba, Philippe, Laccourreye, Laurent, Saada-Bouzid, Esma, Aide, Nicolas, Bénavent, Valérie, Klijianenko, Jerzy, Lamy, Constance, Girard, Elodie, Vacher, Sophie, Masliah-Planchon, Julien, de Koning, Leanne, Puard, Vincent, Borcoman, Edith, Jimenez, Marta, Bièche, Ivan, Gal, Jocelyn, Le Tourneau, Christophe

Volltext

Factors associated with under-reporting of head and neck squamous cell carcinoma in cause-of-death records: A comparative study of two national databases in France from 2008 to 201... von Even, Caroline, Sagaon Teyssier, Luis, Pointreau, Yoann, Temam, Stéphane, Huguet, Florence, Geoffrois, Lionnel, Schwarzinger, Michaël

Volltext

2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France von Gorphe, Philippe, Blanchard, Pierre, Garcia, Gabriel C. T. E, Classe, Marion, Even, Caroline, Temam, Stéphane, Breuskin, Ingrid

Volltext

Prognostic Analysis of HPV Status in Sinonasal Squamous Cell Carcinoma von Tendron, Alexandre, Classe, Marion, Casiraghi, Odile, Pere, Hélène, Even, Caroline, Gorphe, Philippe, Moya-Plana, Antoine

Volltext

Exploratory window‐of‐opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer von Gomez‐Roca, Carlos, Even, Caroline, Le Tourneau, Christophe, Basté, Neus, Delord, Jean‐Pierre, Sarini, Jerome, Vergez, Sebastien, Temam, Stephane, Hoffmann, Caroline, Rochaix, Philippe, Borcoman, Edith, Gavillet, Bruno, Rouits, Elisabeth, Ménétrey, Annick, Brichory, Franck, Purcea, Daniela, Vuagniaux, Gregoire, Zanna, Claudio

Volltext

Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors von Tran, Bao-Tram Thi, Gelin, Aurore, Durand, Sylvère, Texier, Matthieu, Daste, Amaury, Toullec, Clémence, Benihoud, Karim, Breuskin, Ingrid, Gorphe, Philippe, Garic, Florence, Brenner, Catherine, Le Tourneau, Christophe, Fayette, Jérôme, Niki, Toshiro, David, Muriel, Busson, Pierre, Even, Caroline

Volltext

Successful treatment with trastuzumab in HER2-positive squamous cell carcinoma of the head and neck von Saleh, Khalil, MD, Saada, Esma, MD, Auger, Nathalie, MD, Mayache-Badis, Lamia, MD, Casiraghi, Odile, MD, Bidault, Francois, MD, Bahleda, Rastislav, MD, Even, Caroline, MD

Volltext

Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study von EVEN, Caroline, BASTUJI-GARIN, Sylvie, HICHERI, Yosr, PAUTAS, Cécile, BOTTEREL, Francoise, MAURY, Sébastien, CABANNE, Ludovic, BRETAGNE, Stéphane, CORDONNIER, Catherine

Volltext

A Path-Generation Matheuristic for Large Scale Evacuation Planning von Pillac, Victor, Van Hentenryck, Pascal, Even, Caroline

Volltext

NISCAHN: a phase II trial of nivolumab in patients with salivary gland carcinoma (Unicancer ORL-08) von Fayette, Jérôme, Even, Caroline, Digue, Laurence, Geoffrois, Lionnel, Rolland, Fréderic, Cupissol, Didier, Guigay, Joel, Le Tourneau, Christophe, Dillies, Anne Françoise, Zanetta, Sylvie, Bozec, Laurence, Borel, Christian, Couchon-Thaunat, Sophie, Costes-Martineau, Valérie, Sudaka-Bahadoran, Anne, Jallut, Isabelle, Garic, Florence, Lardy-Cleaud, Audrey, Chabaud, Sylvie

Volltext

Nivolumab (Nivo) vs investigator’s choice (IC) for platinum-refractory (PR) recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN; Checkmate 141): Outco... von Gillison, Maura L., Blumenschein, George R., Fayette, Jérôme, Guigay, Joel, Colevas, A. Dimitrios, Licitra, Lisa, Harrington, Kevin, Kasper, Stefan, Vokes, Everett E., Even, Caroline, Worden, Francis P., Saba, Nabil F., Iglesias Docampo, Lara Carmen, Haddad, Robert I., Rordorf, Tamara, Kiyota, Naomi, Tahara, Makoto, Lynch, Mark John, Kopit, Justin, Ferris, Robert L.

Volltext

435 Pegasus HNSCC, a platform study of SAR444245 (THOR-707, a pegylated recombinant non-alpha IL-2) with anti-cancer agents in patients with recurrent/metastatic head and neck squa... von Meng, Robin, Even, Caroline, Licitra, Lisa, Yen, Chia-Jui, Ahn, Myung Ju, Abbadessa, Giovanni, Menas, Fatima-Zohra, Zang, Miao, Blumenschein, George

Volltext

Abstract CT099: Nivolumab (nivo) vs investigator's choice (IC) for recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): CheckMate-141 von Gillison, Maura L., Blumenschein, George, Fayette, Jérôme, Guigay, Joel, Colevas, A. Dimitrios, Licitra, Lisa, Harrington, Kevin, Kasper, Stefan, Vokes, Everett E., Even, Caroline, Worden, Francis, Saba, Nabil F., Iglesias Docampo, Lara Carmen, Haddad, Robert, Rordorf, Tamara, Kiyota, Naomi, Tahara, Makoto, Monga, Manish, Lynch, Mark, Geese, William J., Schactman, Mark, Kopit, Justin, Shaw, James W., Ferris, Robert L.

Volltext

Salivary gland carcinoma: Towards a more personalised approach von Rached, Layal, Saleh, Khalil, Casiraghi, Odile, Even, Caroline

Volltext

Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study von Hsu, Chiun, Lee, Se-Hoon, Ejadi, Samuel, Even, Caroline, Cohen, Roger B, Le Tourneau, Christophe, Mehnert, Janice M, Algazi, Alain, van Brummelen, Emilie M J, Saraf, Sanatan, Thanigaimani, Pradeep, Cheng, Jonathan D, Hansen, Aaron R

Volltext

Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck von Saleh, Khalil, Daste, Amaury, Martin, Nicolas, Pons-Tostivint, Elvire, Auperin, Anne, Herrera-Gomez, Ruth Gabriela, Baste-Rotllan, Neus, Bidault, Francois, Guigay, Joel, Le Tourneau, Christophe, Saada-Bouzid, Esma, Even, Caroline

Volltext

Complete response upon salvage chemotherapy after anti-PD1 failure: Watch and wait von Saleh, Khalil, Bellanger, Christophe, Garcia, Gabriel, Classe, Marion, Even, Caroline

Volltext